ImmunoPrecise Antibodies Ltd

NASDAQ:IPA   3:59:54 PM EDT
6.36
-0.18 (-2.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

ImmunoPrecise Antibodies Ltd Stock, NASDAQ:IPA

4464 Markham Street, Suite 3204, Victoria, British Columbia V8Z 7X8
Canada
Phone: +1.250.483.0308
Number of Employees: 73

Description

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.